Journal of Research in Ayurvedic Sciences

Register      Login

VOLUME 2 , ISSUE 1 ( January-March, 2018 ) > List of Articles

RESEARCH ARTICLE

Integration of AYUSH (Ayurveda and Yoga) with National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS): An Appraisal of Central Council for Research in Ayurvedic Sciences Research and Development Initiatives

Sandhya Rani, Arun Bhadula, Vinod K Shahi, Bharti

Keywords : Integration, Lifestyle, Noncommunicable disease.

Citation Information : Rani S, Bhadula A, Shahi VK, B. Integration of AYUSH (Ayurveda and Yoga) with National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS): An Appraisal of Central Council for Research in Ayurvedic Sciences Research and Development Initiatives. J Res Ayurvedic Sci 2018; 2 (1):27-36.

DOI: 10.5005/jp-journals-10064-0036

License: CC BY-NC 3.0

Published Online: 00-03-2018

Copyright Statement:  Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Introduction: Noncommunicable diseases (NCDs) include cardiovascular diseases, diabetes, hypertension, stroke, cancer, etc. Such diseases mainly result from lifestyle-related factors, such as unhealthy diet, lack of physical activity, use of tobacco, etc. Changes in lifestyles, behavioral patterns, demographic profile, sociocultural and technological advancements lead to sharp increase in the prevalence of NCDs. These diseases, by and large, can be prevented by making simple changes in the way people live their lives or by simply changing our lifestyle. Aims and objectives: Central Council of Research in Ayurvedic Sciences, Ministry of AYUSH in collaboration with Directorate General of Health Services, Ministry of Health and Family Welfare has implemented and executed a program, viz., Integration of AYUSH (Ayurveda) component with National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) program in the identified districts of three states, viz., Bhilwara (Rajasthan), Surendranagar (Gujarat), and Gaya (Bihar), with an aim to cater health care services and to reduce the burden of NCDs by combining the strength of Ayurveda and Yoga. Materials and methods: This program has been implemented on a pilot basis in three districts of the three states at three district hospitals (DHs), 49 community health centers (CHCs), and 183 primary health centers (PHCs) (71 at Gaya, 37 at Surendranagar, and 75 at Bhilwara). In view of etiology of NCDs’ pharmacological and nonpharmacological interventions, lifestyle and Yoga have been advocated. Sixteen common Ayurvedic medicines were identified for the prevention and management of the NCDs. Training to human resource was provided through various training programs before implementation. Outcomes: The aforesaid program is successfully functional in 52 centers (49 CHCs and 3 DHs) of all the three identified districts. This program boosted the referrals and cross-referrals of patients among conventional and various AYUSH systems.


PDF Share
  1. World Health Organization. Media centre. Noncommunicable diseases. Key facts. Geneva: WHO; 2017 [cited 2017 Jun 21]. Available from: http://www.who.int/mediacentre/ factsheets/fs355/en/.
  2. Ministry of Health and Family Welfare. Annual report 2014-15. Chapter 11: Other national health programmes. New Delhi: Ministry of Health and Family Welfare; 2014-2015. p. 165-184. Available from: http://mohfw.nic.in/sites/ default/files/7896321456325698.pdf.
  3. World Health Organization. Global status report on non communicable diseases. Geneva: WHO; 2010. p. 2. Available from: http://www.who.int/nmh/publications/ncd_report_ full_en.pdf.
  4. Directorate General of Health Services, Ministry of Health and Family Welfare. National programme for prevention and control of cancer, diabetes, cardiovascular diseases and stroke. New Delhi: Ministry of Health and Family Welfare, Gov. of India; 2008. [cited 2017 Jul 13]. Available from: http://dghs.gov.in/content/1363_3_NationalProgrammePreventionControl.aspx.
  5. Vaghbhatt, Astanga Hyridyam with the ‘Vidyotini’ ‘Nirmala’ Hindi commentary, edited by Vaidya Acharya Jaimeeni Pandey. Vol. 1. Sutrasthan 4/36. Varanasi: Chaukambha Sanskrit Bhawan; 2010. p. 74.
  6. Bhavmishra-Bhavprakash, commentary by Dr. Bulusu Sitaram. Vol. 1. Chapter 5/2. Varanasi: Chaukhambha Orientalia; 2006. p. 67.
  7. National Health Policy. Reduction of disease prevalence and incidence. New Delhi: Ministry of Health and Family Welfare, Gov. of India; 2017. p. 4. Available from: www.nhp. gov.in/NHPfiles/national_health_policy_2017.pdf.
  8. Ministry of AYUSH, Govt. of India. Research Councils. Central Council for Research in Ayurvedic Sciences. New Delhi: Ministry of AYUSH; 2015 [cited 2017 May 2]. Available from: http://ayush.gov.in/research/researchcouncils.
  9. Agnivesh. C. Charak Samhita. In: Yadavaji trikamji Acharya V, editor. Shyamatrivrutkalpa adhyaya, 7/12. 5th ed. Varanasi: Chaukhambha Sanskrit Sansthana; 2011. p. 662.
  10. Sharngadhara, Sharngadhara Samhita, Purvakhanda, In: Parshuram Shastri P, editor. Dipanapachana Adhyaya, 4/6. 7th ed. Varanasi: Chaukhambha Orientalia; 2008. p. 36.
  11. Agnivesh, C. Charak Samhita. In: Yadavaji Trikamji Acharya V, editor. Shyamatrivrutkalpa Adhyaya, 7/12. 5th ed. Varanasi: Chaukhambha Sanskrit Sansthana; 2011.
  12. Anonymous. Ayurvedic pharmacopoeia of India. Part I. Vol. 2. Appendix 5. New Delhi: Govt. of India, Department of Health and Family Welfare, Department of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH); p. 262.
  13. Vaghbhat. Ashtanga Hrudaya, Sutrasthana. In: Hari Sadashiv Shastri PT, editor. Vamanvirechana Vidhi, 18/33. Varanasi: Chaukhambha Surabharati Prakashana; 2010. p. 266.
  14. World Gastroenterology Organization. Global guidelines constipation: a global perspective. Milwaukee (WI): WGO; 2010. Available from: www.worldgastroenterology.org/ assets/export/05_constipation.
  15. Agnivesh, C. Charak Samhita. In: Yadavaji Trikamji Acharya V, editor. Sutrasthana, Navegandharaniy Adhyaya, 7/8. 5th ed. Varanasi: Chaukhambha Sanskrit Sansthana; 2011. p. 49.
  16. Vaghbhat, Ashtanga Hrudaya, Sutrasthana, Sutrasthana. In: Hari Sadashiv Shastri PT, editor. Rasabhediya Adhyaya, 10/38. Varanasi: Chaukhambha Surabharati Prakashana; 2010. p. 181.
  17. Vaghbhat, Ashtanga Hrudaya, Sutrasthana, Sutrasthana. In: Hari Sadashiv Shastri PT, editor. Ayushkamiya Adhyaya, 1/10. Varanasi: Chaukhambha Surabharati Prakashana; 2010. p. 9.
  18. Sushruta, Sushruta Samhita, Uttarsthana, Sharirasthana. In: Yadavji Trikamji Acharya V, editor. Garbhvyakarana Adhyaya, 4/38. Varanasi: Chaukhambha Surbharati Prakashana; 2008. p. 359.
  19. Vaghbhat, Ashtanga Hrudaya, Sutrasthana, Sutrasthana, Nidansthaan., In: Hari Sadashiv Shastri PT, editor. Vatashonita Nidana, 16/27. Varanasi: Chaukhambha Surabharati Prakashana; 2010. p. 538.
  20. Gibbon, JD. Statistical theory and inference in research. 4th ed. Switzerland: Eastern Hemisphere Distribution; 2003.
  21. Agnivesh, C. Charak Samhita. In: Yadavaji Trikamji Acharya V, editor. Sutrasthana, Sutrasthana, Kiyantahshirasiya Adhyaya, 17/70. 5th ed. Varanasi: Chaukhambha Sanskrit Sansthana; 2011. p. 103.
  22. Tyler, VE.; Brany, LR.; Robberes, JE. Pharmacognosy. 9th ed. Philadelphia (PA): Lea and Febiger; 1988. p. 67.
  23. Watson JT, Jones RC, Siston AM, Diaz PS, Gerber SI, Crowe JB, Satzger RD. Outbreak of food-borne illness associated with plant material containing raphides. Clin Toxicol (Phila) 2005 Jan;43(1):17-21.
  24. Sushruta, Sushruta Samhita, Uttarsthana, Sutrasthana. In: Yadavji Trikamji Acharya V, editor. Rasavisheshvidnyaniya Adhyaya, 42/15. Varanasi: Chaukhambha Surbharati Prakashana; 2008. p. 185.s
  25. Yadahalli SL. The study of Virechana Karma and its effect on body fluids w.s.r.t serum electrolytes—an observational study. Available from: www.slideshare.net/ayurmitra/ virechana-electrolytes.
  26. Rasika Kolhe, Rabinarayan Acharya, Mukesh Nariya. Comparative screening of intestinal transit time of three available source drugs of Trivrut in Swice albino mice. Joinsymed 2016; 4(4):192-195.
  27. Alizadeh-Navaei R, Roozbeh F, Saravi M, Pouramir M, Jalali F, Moghadamnia AA. Investigation of the effect of ginger on the lipid levels. A double blind controlled clinical trial. Saudi Med J 2008 Sep;29(9):1280-1284.
  28. Goel A, Dharurkar P, Shah A, Gore S, More S, Ranjan S. Only spinal fixation as treatment of prolapsed cervical intervertebral disc in patients presenting with myelopathy. J Craniovertebr Junction Spine. 2017 Oct-Dec;8(4):305-310.
  29. Goel A, Kaswa A, Shah A, Rai S, Gore S, Dharurkar P. Extraspinal-Interdural Surgical Approach for C2 Neurinomas-Report of an Experience with 50 Cases. World Neurosurg. 2018 Feb;110:575-582.
  30. Goel A, Jain S, Shah A, Patil A, Vutha R, Ranjan S, More S. Atlantoaxial Fixation for Odontoid Fracture: Analysis of 124 Surgically Treated Cases. World Neurosurg. 2018 Feb;110:558-567.
  31. Goel A, Jain S, Shah A.Radiological Evaluation of 510 Cases of Basilar Invagination with Evidence of Atlantoaxial Instability (Group A Basilar Invagination). World Neurosurg. 2018 Feb;110:533-543.
  32. Goel A, Bhaganagare A, Shah A, Kaswa A, Rai S, Dharurkar P, Gore S. Olfactory groove meningiomas: An analysis based on surgical experience with 129 cases. Neurol India. 2018 Jul-Aug;66(4):1081-1086.
  33. Goel A, Nadkarni T: Surgical management of giant pituitary tumours- a study of 30 cases. Acta Neurochir (Wien) 138; 1042- 1049, 1996.
  34. Goel A: The extradural approach to lesions involving cavernous sinus. Br J Neurosurg 11(2): 134-138, 1997
  35. Goel A, Muzumdar D, Desai K: Tuberculum sellae meningioma: A report on management on the basis of a surgical experience with 70 cases. Neurosurgery) 51:1358-1364,2002.
  36. Goel A, Muzumdar D, Raman C: Trigeminal neuroma: An analysis of a surgical experience with 73 cases. Neurosurgery 52:783- 790,2003.
  37. Goel A, Nadkarni T, Muzumdar D, Desai K, Phalke U, Sharma P: Giant pituitary tumors: a study based on surgical treatment of 118 cases. Surg Neurol. 2004 May;61(5):436-445.
  38. Goel A: Treatment of basilar invagination by atlantoaxial joint distraction and direct lateral mass fixation. J Neurosurg Spine. 2004 Oct;1(3):281-6.
  39. Goel A, Muzumdar, Desai K Anterior tentorium-based epidermoid tumours: Results of radical surgical treatment in 96 cases. “Br J Neurosurg. 2006 Jun;20(3):139-45.
  40. Malvankar-Mehta MS, Chen YN, Iordanous Y, Wang WW, Costella J, Hutnik CML. iStent as a solo procedure for glaucoma patients: a systematic review and meta-analysis. PLoS One2015;10(5):e0128146.
  41. Malvankar-Mehta MS, Iordanous Y, Chen YN. iStent with phacoemulsification versus phacoemulsification alone for patients with glaucoma and cataract: a meta-analysis. PLoS One2015;10(7):e0131770.
  42. Bahler CK, Smedley GT, Zhou J, Johnson DH. Trabecular bypass stents decrease intraocular pressure in cultured human anterior segments. Am J Ophthalmol2004;138(6):988-994.
  43. Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC. Postoperative complications in the tube versus trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol2012;153(5):804-814.
  44. Iordanous Y, Kent JS, Hutnik CML, Malvankar-Mehta MS. Projected cost comparison of Trabectome, iStent, and endoscopic cyclophotocoagulation versus glaucoma medication in the Ontario Health Insurance Plan. J Glaucoma2014;23:e112-118.
  45. Kaplowitz K, Bussel II, Honkanen R, Schuman JS, Loewen NA. Review and meta-analysis of ab-interno trabeculectomy outcomes. Br J Ophthalmol 2016;100(5):594-600.
  46. Almeida Junior GC, Arakawa L, Santi Neto DD, Cury PM, Lima Filho AA, Sousa SJ, Alves MR, Azoubel R. Preoperative tranilast as adjunctive therapy to primary pterygium surgery with a 1-year follow-up. Arq Bras Oftalmol 2015 Jan-Feb; 78(1):1-5.
  47. Bahar I, Lusky M, Gaton D, Robinson A, Avisar R, Weinberger D. The use of fibrin adhesive in trabeculectomy: a pilot study. Br J Ophthalmol 2006 Nov;90(11):1430.
  48. Bahar I, Weinberger D, Lusky M, Avisar R, Robinson A, Gaton D. Fibrin glue as a suture substitute: histological evaluation of trabeculectomy in rabbit eyes. Curr Eye Res 2006 Jan;31(1):31-36.
  49. Buschmann W, Stemberger A, Blumel G, Leydhecker W. Fibrin adhesion and postoperative anti-fibrinolytic care of conjunctival wounds. Klin Monatsbl Augenheilkd 1984 Mar;184(3):185-188.
  50. Choudhari NS, Neog A, Latka S, Srinivasan B. Fibrin sealantassisted revision of the exposed Ahmed tube. Middle East Afr J Ophthalmol 2015 Jan-Mar;22(1):115-116.
  51. Choudhari NS, Neog A, Sharma A, Iyer GK, Srinivasan B. Authors' reply. Indian J Ophthalmol 2013 Jun;61(6):312-313.
  52. Choudhari NS, Neog A, Sharma A, Iyer GK, Srinivasan B. Our experience of fibrin sealant-assisted implantation of Ahmed glaucoma valve. Indian J Ophthalmol 2013 Jan-Feb;61(1): 23-27.
  53. Dal Pizzol MM, Roggia MF, Kwitko S, Marinho DR, Rymer S. Use of fibrin glue in ocular surgery. Arq Bras Oftalmol 2009 May-Jun;72(3):308-312.
  54. Dintelmann T, Lieb WE, Grehn F. Filtering bleb revision. Techniques and outcome. Ophthalmologe 2002 Dec;99(12): 917-921.
  55. Du TT, Saffra N. Acellular dermal graft as a treatment of recurrent conjunctival wound dehiscence. Arch Ophthalmol 2009 Nov;127(11):1520-1521.
  56. Elmalem VI, Harris GJ. Occurrence and surgical management of a cerebrospinal fluid-filled cystoid space following routine enucleation. Ophthal Plast Reconstr Surg 2012 Sep-Oct;28(5):e117-e118.
  57. Esquenazi S, Rand W, Velazquez G, Grunstein L. Novel therapeutic approach in the management of band keratopathy using amniotic membrane transplantation with fibrin glue. Ophthalmic Surg Lasers Imaging 2008 Sep-Oct;39(5): 418-421.
  58. Freeman PD, Kahook MY, Curtis TH. Glaucoma drainage device implantation in children using fibrin glue. J AAPOS 2010 Apr;14(2):169-171.
  59. Piltz JR, Starita RJ. The use of subconjunctivally administered tissue plasminogen activator after trabeculectomy. Ophthalmic Surg 1994 Jan;25(1):51-53.
  60. Por YM, Tan YL, Mehta JS, Tan DT. Intracameral fibrin tissue sealant as an adjunct in tectonic lamellar keratoplasty for large corneal perforations. Cornea 2009 May;28(4):451-455.
  61. Sakarya Y, Sakarya R, Yildirim A. Sutureless amniotic membrane fixation with fibrin glue in symptomatic bullous keratopathy with poor visual potential. Eur J Ophthalmol 2010 Jan-Feb;20(1):249; author reply 249-250.
  62. Lee GA, Holcombe DJ. Surgical revision of dysfunctional filtration blebs with bleb preservation sliding conjunctival flap and fibrin glue. Eye (Lond) 2010 Jun;24(6):947-953.
  63. Kahook MY, Noecker RJ. Fibrin glue-assisted glaucoma drainage device surgery. Br J Ophthalmol 2006 Dec;90(12):1486-1489.
  64. Valimaki J. Fibrin glue for preventing immediate postoperative hypotony following glaucoma drainage implant surgery. Acta Ophthalmol Scand 2006 Jun;84(3):372-374.
  65. Malhotra C, Jain AK. Human amniotic membrane transplantation: different modalities of its use in ophthalmology. World J Transplant 2014 Jun;4(2):111-121.
  66. Dua HS, Gomes JA, King AJ, Maharajan VS. The amniotic membrane in ophthalmology. Surv Ophthalmol 2004 Jan-Feb;49(1):51-77.
  67. Shimmura S, Shimazaki J, Ohashi Y, Tsubota K. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea 2001 May;20(4):408-413.
  68. Yazdani S, Mahboobipour H, Pakravan M, Doozandeh A, Ghahari E. Adjunctive mitomycin c or amniotic membrane transplantation for Ahmed glaucoma valve implantation: a randomized clinical trial. J Glaucoma 2016 May;25(5):415-421.
  69. Sheha H, Kheirkhah A, Taha H. Amniotic membrane transplantation in trabeculectomy with mitomycin C for refractory glaucoma. J Glaucoma 2008 Jun-Jul;17(4):303-307.
  70. Khairy HA, Elsawy MF. Trabeculectomy with mitomycin-C versus trabeculectomy with amniotic membrane transplant: a medium-term randomized controlled trial. J Glaucoma 2015 Sep;24(7):556-559.
  71. Rauscher FM, Barton K, Budenz DL, Feuer WJ, Tseng SC. Long-term outcomes of amniotic membrane transplantation for repair of leaking glaucoma filtering blebs. Am J Ophthalmol 2007 Jun;143(6):1052-1054.
  72. Sethi P, Patel RN, Goldhardt R, Ayyala RS. Conjunctival advancement with subconjunctival amniotic membrane draping technique for leaking cystic blebs. J Glaucoma 2016 Feb;25(2):188-192.
  73. Kitagawa K, Yanagisawa S, Watanabe K, Yunoki T, Hayashi A, Okabe M, Nikaido T. A hyperdry amniotic membrane patch using a tissue adhesive for corneal perforations and bleb leaks. Am J Ophthalmol 2009 Sep;148(3):383-389.
  74. Nagai-Kusuhara A, Nakamura M, Fujioka M, Negi A. Longterm results of amniotic membrane transplantation-assisted bleb revision for leaking blebs. Graefes Arch Clin Exp Ophthalmol 2008 Apr;246(4):567-571.
  75. Rai P, Lauande-Pimentel R, Barton K. Amniotic membrane as an adjunct to donor sclera in the repair of exposed glaucoma drainage devices. Am J Ophthalmol 2005 Dec;140(6): 1148-1152.
  76. Ainsworth G, Rotchford A, Dua HS, King AJ. A novel use of amniotic membrane in the management of tube exposure following glaucoma tube shunt surgery. Br J Ophthalmol 2006 Apr;90(4):417-419.
  77. Papadaki TG, Siganos CS, Zacharopoulos IP, Panteleontidis V, Charissis SK. Human amniotic membrane transplantation for tube exposure after glaucoma drainage device implantation. J Glaucoma 2007 Jan;16(1):171-172.
  78. Mulder EJ, Leiblum DM, Visser GH. Fetal breathing movements in late diabetic pregnancy: relationship to fetal heart rate patterns and Braxton Hicks’ contractions. Early Hum Dev 1995 Nov;43(3):225-232.
  79. Schulte FJ, Michaelis R, Nolte R, Albert G, Parl U, Lasson U. Brain and behavioral maturation in newborn infants of diabetic mothers. I. Nerve conduction and EEG patterns. Neuropadiatrie 1969 Jan-Jul;1(1):24-35.
  80. Devoe LD, Youssef AA, Castillo RA, Croom CS. Fetal biophysical activities in third-trimester pregnancies complicated by diabetes mellitus. Am J Obstet Gynecol 1994 Aug;171(2):298-303.
  81. Dierker LJ Jr, Pillay S, Sorokin Y, Rosen MG. The change in fetal activity periods in diabetic and nondiabetic pregnancies. Am J Obstet Gynecol 1982 May;143(2):181-185.
  82. Doherty NN, Hepper PG. Habituation in fetuses of diabetic mothers. Early Hum Dev 2000 Aug;59(2):85-93.
  83. Kainer F, Prechtl HF, Engele H, Einspieler C. Assessment of the quality of general movements in fetuses and infants of women with type-1 diabetes mellitus. Early Hum Dev 1997 Nov;50(1):13-25.
  84. Mulder EJ, O'Brien MJ, Lems YL, Visser GH, Prechtl HF. Body and breathing movements in near-term fetuses and newborn infants of type-1 diabetic women. Early Hum Dev 1990 Nov;24(2):131-152.
  85. Mulder EJ, Visser GH. Growth and motor development in fetuses of women with type-1 diabetes. I. Early growth patterns. Early Hum Dev 1991 May;25(2):91-106.
  86. Mulder EJ, Visser GH. Growth and motor development in fetuses of women with type-1 diabetes. II. Emergence of specific movement patterns. Early Hum Dev 1991 May;25(2):107-115.
  87. Mulder EJ, Visser GH. Impact of early growth delay on subsequent fetal growth and functional development: a study on diabetic pregnancy. Early Hum Dev 1992 Dec;31(2):91-95.
  88. Mulder EJ, Visser GH, Bekedam DJ, Prechtl HF. Emergence of behavioral states in fetuses of type-1 diabetic women. Early Hum Dev 1987 Jul;15(4):231-251.
  89. Mulder EJ, Visser GH, Morssink LP, de Vries JI. Growth and motor development in fetuses of women with type-1 diabetes. III. First trimester quantity of fetal movement patterns. Early Hum Dev 1991 May;25(2):117-133.
  90. Aberg A, Westbom L, Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev 2001 Mar;61(2):85-95.
  91. Deregnier RA, Nelson CA, Thomas KM, Wewerka S, Georgieff MK. Neurophysiologic evaluation of auditory recognition memory in healthy newborn infants and infants of diabetic mothers. J Pediatr 2000 Dec;137(6):777-784.
  92. Nelson CA, Wewerka S, Thomas KM, Tribby-Walbridge S, deRegnier R, Georgieff M. Neurocognitive sequelae of infants of diabetic mothers. Behav Neurosci 2000 Oct;114(5):950-956.
  93. Reece EA, Homko CJ. Infant of the diabetic mother. Semin Perinatol 1994 Oct;18(5):459-469.
  94. Reece EA, Homko CJ. Why do diabetic women deliver malformed infants? Clin Obstet Gynecol 2000 Mar;43(1):32-45.
  95. Rizzo T, Metzger BE, Burns WJ, Burns K. Correlations between antepartum maternal metabolism and intelligence of offspring. N Engl J Med 1991 Sep;325(13):911-916.
  96. Rizzo TA, Metzger BE, Dooley SL, Cho NH. Early malnutrition and child neurobehavioral development: insights from the study of children of diabetic mothers. Child Dev 1997 Feb;68(1):26-38.
  97. Schwartz R, Teramo KA. Effects of diabetic pregnancy on the fetus and newborn. Semin Perinatol 2000 Apr;24(2):120-135.
  98. Vaarasmaki MS, Hartikainen A, Anttila M, Pramila S, Koivisto M. Factors predicting peri- and neonatal outcome in diabetic pregnancy. Early Hum Dev 2000 Jul;59(1):61-70.
  99. Robertson SS, Dierker LJ. Fetal cyclic motor activity in diabetic pregnancies: sensitivity to maternal blood glucose. Dev Psychobiol 2003 Jan;42(1):9-16.
  100. Accardo PJ, Blondis TA, Whitman BY. Disorders of attention and activity level in a referral population. Pediatrics 1990 Mar;85(3 Pt 2):426-431.
  101. Ornoy A, Uriel L, Tennenbaum A. Inattention, hyperactivity and speech delay at 2-4 years of age as a predictor for ADDADHD syndrome. Isr J Psychiatry Relat Sci 1993;30(3):155-163.
  102. Smyth TR. Impaired motor skill (clumsiness) in otherwise normal children: a review. Child Care Health Dev 1992 Sep-Oct;18(5):283-300.
  103. Petersen MB, Pedersen SA, Greisen G, Pedersen JF, Mølsted- Pedersen L. Early growth delay in diabetic pregnancy: relation to psychomotor development at age 4. Br Med J (Clin Res Ed) 1988 Feb;296(6622):598-600.
  104. Sells CJ, Robinson NM, Brown Z, Knopp RH. Long-term developmental follow-up of infants of diabetic mothers. J Pediatr 1994 Jul;125(1):S9-S17.
  105. Vladareanu R, Lebit D, Constantinescu S. Ultrasound assessment of fetal neurobehaviour in high risk pregnancies. DSJUOG 2012 Apr-Jun;6(2):132-147.
  106. Talic A, Kurjak A, Ahmed B, Stanojevic M, Predojevic M, Kadic AS, Di Renzo GC. The potential of 4D sonography in the assessment of fetal behavior in high-risk pregnancies. J Matern Fetal Neonatal Med 2011 Jul;24(7):948-954.
  107. Bekedam DJ, Visser GH, de Vries JJ, Prechtl HF. Motor behaviour in the growth retarded fetus. Early Hum Dev 1985 Nov;12(2):155-165.
  108. Cioni G, Prechtl HF. Preterm and early postterm motor behaviour in low-risk premature infants. Early Hum Dev 1990 Sep;23(3):159-191.
  109. Seme-Ciglenecki P. Predictive value of assessment of general movements for neurological development of highrisk preterm infants: comparative study. Croat Med J 2003 Dec;44(6):721-727.
  110. Abo-Yaqoub S, Kurjak A, Mohammed AB, Shadad A, Abdel-Maaboud M. The role of 4-D ultrasonography in prenatal assessment of fetal neurobehaviour and prediction of neurological outcome. J Matern Fetal Neonatal Med 2012 Mar;25(3):231-236.
  111. Athanasiadis AP, Mikos T, Tambakoudis GP, Theodoridis TD, Papastergiou M, Assimakopoulos E, Tarlatzis BC. Neurodevelopmental fetal assessment using KANET scoring system in low and high-risk pregnancies. J Matern Fetal Neonatal Med 2013 Mar;26(4):363-368.
  112. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012 Jan;97(1):28-38.e25
  113. Sirmans SM, Pate KA. Epidemiology, diagnosis and management of polycystic ovary syndrome. Clin Epidemiol 2014; 6:1-13.
  114. Fauser BC, Diedrich K, Bouchard P, Domínguez F, Matzuk M, Franks S, Hamamah S, Simón C, Devroey P, Ezcurra D, et al. Contemporary genetic technologies and female reproduction. Human Reproduction Update 2011 Nov;17(6):829-847.
  115. Balen A, Conway G, Kaltsas G. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995 Aug;10(8):2107-2111.
  116. Azziz R, Sanchez L, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004 Feb;89(2):453-462.
  117. Wild S, Pierpoint T, McKeigue P, Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at longterm follow-up: a retrospective cohort study. Clin Endocrinol (Oxf) 2000 May;52(5):595-600.
  118. Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 2007 Jun;87(6): 1369-1376.
  119. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome. In: Givens JHF, Merriman G, editors. The polycystic ovary syndrome. Cambridge, MA: Blackwell Scientific; 1992. p. 377-384.
  120. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004 Jan;81(1):19-25.
  121. Azziz R, Carmina E, DeWailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006 Nov;91(11):4237-4245.
  122. Lujan ME, Jarrett BY, Brooks ED, Reines JK, Peppin AK, Muhn N, Haider E, Pierson RA, Chizen DR. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume. Hum Reprod 2013 May;28(5):1361-1368.
  123. Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. Int J Womens Health 2011 Feb;3:25-35.
  124. ACOG Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No 108: Polycystic ovary syndrome. Obstet Gynecol 2009 Oct;114(4):936-949.
  125. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008 Mar;89(3): 505-522.
  126. Balen AH. Ovulation induction in the management of anovulatory polycystic ovary syndrome. Mol Cell Endocrinol 2013 Jul;373(1-2):77-82.
  127. Berridge DL, Winter TC. Saline infusion sonohysterography: technique, indications, and imaging findings. J Ultrasound Med 2004 Jan;23(1):97-112.
  128. Allison SJ, Horrow MM, Kim HY, Lev-Toaff AS. Salineinfused sonohysterography: tips for achieving greater success. Radiographics 2011 Nov-Dec;31(7):1991-2004.
  129. O'Neill MJ. Sonohysterography. Radiol Clin North Am 2003 Jul;41(4):781-797.
  130. Bonnamy L, Marret H, Perrotin F, Body G, Berger C, Lansac J. Sonohysterography: a prospective survey of results and complications in 81 patients. Eur J Obstet Gynecol Reprod Biol 2002 Apr;102(1):42-47.
  131. Lindheim SR, Adsuar N, Kushner DM, Pritts EA, Olive DL. Sonohysterography: a valuable tool in evaluating the female pelvis. Obstet Gynecol Surv 2003 Nov;58(11):770-784.
  132. Lindheim SR, Sprague C, Winter TC. Hysterosalpingography and sonohysterography: lessons in technique. AJR Am J Roentgenol 2006 Jan;186(1):24-29.
  133. Jeanty P, Besnard S, Arnold A, Turner C, Crum P. Air-contrast sonohysterography as a first step assessment of tubal patency. J Ultrasound Med 2000 Aug;19(8):519-527.
PDF Share